Proof-of-concept Study to Assess the Efficacy and Safety of SRX246 in Adults With PTSD

NCT02733614 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

33

Enrollment

INDUSTRY

Sponsor class

Stopped funding

Conditions

PTSD

Interventions

DRUG: SRX246
DRUG: Placebo

Sponsor

Azevan Pharmaceuticals

Collaborators

[object Object]
[object Object]
[object Object]